Inventor
Gottfried Himmler
Inventor
Vienna, AT
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61KPreparations for medical, dental or toiletry purposes17%
C12NMicroorganisms or enzymes11%
C40BCombinatorial chemistry8%
Y02ATechnologies for adaptation to climate change6%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
B82YSpecific uses or applications of nanostructures1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
11,084,868Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions202110,385,118Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions201910,189,905Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies201910,125,197Cytotoxic immunoglobulin201810,059,777Secretory immunoglobulin complex20189,856,311'Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions'20189,651,559'Display of binding agents'20179,636,415'Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies'20179,255,149'Cytotoxic immunoglobulin'20169,133,274'Method for engineering immunoglobulins'20159,079,765'Nanoparticles comprising antigens and adjuvants, and immunogenic structures'20159,045,528'Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions'20158,921,279'Display of binding agents'20148,859,738'Cytotoxic immunoglobulin'20148,323,650'Method of treating lewis Y-expressing tumors'20128,034,338'Immunogenic recombinant antibody'20117,759,464'N-glycosylated antibody'20107,527,789'Use of a preparation based on an antibody directed against a tumor-associated glycosylation'20096,033,881'Method for one step isothermal non-transcription based amplification of nucleic acids'20005,866,694'Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates'19995,756,674'Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates'19985,693,752'Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2018Based in Vienna, AT· patent location history
2012–2018Patents assigned to HIMMLER GOTTFRIED (8)· patent assignee history
2012–2015Patents assigned to REDL GERDA (4)· patent assignee history
2014–2016Patents assigned to F STAR BIOTECH FORSCH & ENTW (5)· patent assignee history
2014–2018Patents assigned to RUKER FLORIAN (4)· patent assignee history
2014–2018Patents assigned to WOZNIAK-KNOPP GORDANA (4)· patent assignee history
2014–2021Based in Gross-Enzersdorf, AT· patent location history
2019Based in Gross Enzerdorf, AT· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HIMMLER GOTTFRIEDself | 8 | 2012–2018 |
| F STAR BIOTECH FORSCH & ENTW | 5 | 2014–2016 |
| REDL GERDA | 4 | 2012–2015 |
| RUKER FLORIAN | 4 | 2014–2018 |
| WOZNIAK-KNOPP GORDANA | 4 | 2014–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vienna, AT | 13 | 1997–2018 |
| Gross-Enzersdorf, AT | 8 | 2014–2021 |
| Gross Enzerdorf, AT | 1 | 2019 |